A pre-operative prognostic model predicting all cause and cause specific mortality for women presenting with invasive breast cancer
- PMID: 34891035
- PMCID: PMC8661050
- DOI: 10.1016/j.breast.2021.12.002
A pre-operative prognostic model predicting all cause and cause specific mortality for women presenting with invasive breast cancer
Abstract
Purpose: The aim of this study is to develop a pre-operative prognostic model based on known pre-operative factors.
Methods: A database of ultrasound (US) lesions undergoing biopsy documented US lesion size, stiffness, and patient source prospectively. Women with invasive cancer presenting between 2010 and 2015 were the study group. Breast and axillary core results and ER, PR and HER receptor status were collected prospectively. Assessment of US skin thickening, US distal enhancement and presence of chronic kidney disease (CKD) was performed retrospectively. Patient survival and cause of death were ascertained from computer records. Predictive models for (i) all-cause mortality (ACM) and (ii) breast cancer death (BCD) were built and then validated using bootstrap k-fold cross-validation. A comparison of predictive performance was made between a full cause-specific Cox model, a sub cause-specific Cox model, and a full Fine-Gray sub-distribution hazard model.
Results: 1136 patients were included in the study. The median follow-up time was 6.2 years. 125 (11%) women died from breast cancer and 155 (14%) died from other causes. For the prediction of BCD, the cause-specific Cox sub-model performed the best. The time dependent AUC begins above 0.91 in year one to 3 reducing to 0.83 in year 6. The factors included in the Cox sub model were tumour size, skin thickening, source of detection, tumour grade, ER status, pre-operative nodal metastasis and CKD.
Conclusion: We have shown that a model based on preoperative factors can predict BCD. Such prediction if externally validated and incorporating treatment data could be useful for treatment planning and patient counselling.
Keywords: Core biopsy; Prediction; Preoperative; Prognosis; Ultrasound.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare no conflicts of interest, competing interests or appropriate disclosures.
Figures
References
-
- Cain H., Macpherson I.R., Beresford M., Pinder S.E., Pong J., Dixon J.M. Neoadjuvant therapy in early breast cancer: treatment considerations and common debates in practice. Clin Oncol. 2017;10:642–652. - PubMed
-
- Sharifi S., Peterson M.K., Baum J.K., Raza S., Schnitt S.J. Assessment of pathologic prognostic factors in breast core needle biopsies. Mod Pathol. 1999;10:941–945. - PubMed
-
- Ahmeidat H., Purdie C., Jordan L., Fleming D., McCullough J., Evans A. Non-histopathological parameters associated with upgrade of breast tumours yielding a core biopsy report of histological grade 2 ductal no special type to grade 3 on excision. EJSO. 2018;44:1720–1924. - PubMed
-
- Evans A., Sim Y.T., Pourreyron C., Thompson A., Jordan L., Fleming D., Purdie C., Macaskill J., Vinnicombe S., Pharoah P. Pre-operative stromal stiffness measured by shear wave elastography is independently associated with breast cancer-specific survival. Breast Cancer Res Treat. 2018;171:383–389. - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
